Bottom line
What is ABRRX's expense ratio?
ABRRX's expense ratio is 1.66%, or about $166 a year on every $10,000 invested. That is more expensive than 88% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 27, 2026
ABRRX fee table
| Net expense ratio | 1.66% |
|---|---|
| Gross expense ratio | 1.71% |
| Management fee | 0.92% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.2% |
| Acquired fund fees | 0.09% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What ABRRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ABRRX | $169 | $534 | $923 | $2,015 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.66% expense ratio costs roughly $86,800 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).